Hutson Nancy J — SEC Form 4 filings

SEC reporting owner CIK 1379222. 5 Form 4 filings on record with FilingPulse; latest filed 2025-06-16.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-05-22 to 2025-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOCRYST PHARMACEUTICALS INC (BCRX)Director41 leg · 5,000 sh · $31,9001 leg · 7,000 sh · $52,7804
Clearside Biomedical, Inc. (CLSD)Director11

Form 4 filings — Hutson Nancy J

FiledFormIssuerReported transactionsSource
2025-06-164BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 12,500 @ $0 · Grant/award (A): 27,181 (derivative) @ $0EDGAR
2024-12-164BIOCRYST PHARMACEUTICALS INC (BCRX)Sale (S): 7,000 @ $7.54EDGAR
2024-06-214Clearside Biomedical, Inc. (CLSD)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2024-06-144BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 6,820 @ $0 · Grant/award (A): 49,933 (derivative) @ $0EDGAR
2024-05-224BIOCRYST PHARMACEUTICALS INC (BCRX)Purchase (P): 5,000 @ $6.38EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1379222 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →